CRISPR in the North American popular press

Alessandro Marcon, Zubin Master, Vardit Ravitsky, Timothy Caulfield

Research output: Contribution to journalArticle

Abstract

Purpose: CRISPR is often called one of the century’s most important discoveries and is commonly discussed in terms of its momentous potential impacts. This study analyzed how CRISPR is discussed in the North American popular press, including how it is defined, and which benefits and risks/concerns are attributed to the technology. Methods: Using the Factiva database, we identified 228 relevant, nonduplicated articles containing either “CRISPR” or “C.R.I.S.P.R.,” published in popular US and Canadian news sources between 1 January 2012 and 12 July 2017. Content analysis was performed on the articles. Results: CRISPR is most often discussed in the context of human health (83.8%), compared with animals (26.3%) and plants (20.6%). Nearly all articles (96.1%) presented CRISPR’s potential benefits; 61.4% of articles presented CRISPR-related risks/concerns, the vast majority of which focused on the uncertainty surrounding CRISPR, specifically with respect to germline modifications. Conclusions: Overall, the discourse suggests a strong promotion of CRISPR, but an element of caution is also evident. Technical as well as ethical, legal, and social risks/concerns play a prominent role. This media portrayal of CRISPR might help facilitate more sophisticated and balanced policy responses, where the scientific potential of the technology is highlighted alongside broader social considerations.

Original languageEnglish (US)
JournalGenetics in Medicine
DOIs
StatePublished - Jan 1 2019

Fingerprint

Clustered Regularly Interspaced Short Palindromic Repeats
Technology
Uncertainty

Keywords

  • biotechnology
  • CRISPR
  • ELSI
  • gene editing
  • media

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

CRISPR in the North American popular press. / Marcon, Alessandro; Master, Zubin; Ravitsky, Vardit; Caulfield, Timothy.

In: Genetics in Medicine, 01.01.2019.

Research output: Contribution to journalArticle

Marcon, Alessandro ; Master, Zubin ; Ravitsky, Vardit ; Caulfield, Timothy. / CRISPR in the North American popular press. In: Genetics in Medicine. 2019.
@article{1f71c695b07b45c9bc529d3d57fadc10,
title = "CRISPR in the North American popular press",
abstract = "Purpose: CRISPR is often called one of the century’s most important discoveries and is commonly discussed in terms of its momentous potential impacts. This study analyzed how CRISPR is discussed in the North American popular press, including how it is defined, and which benefits and risks/concerns are attributed to the technology. Methods: Using the Factiva database, we identified 228 relevant, nonduplicated articles containing either “CRISPR” or “C.R.I.S.P.R.,” published in popular US and Canadian news sources between 1 January 2012 and 12 July 2017. Content analysis was performed on the articles. Results: CRISPR is most often discussed in the context of human health (83.8{\%}), compared with animals (26.3{\%}) and plants (20.6{\%}). Nearly all articles (96.1{\%}) presented CRISPR’s potential benefits; 61.4{\%} of articles presented CRISPR-related risks/concerns, the vast majority of which focused on the uncertainty surrounding CRISPR, specifically with respect to germline modifications. Conclusions: Overall, the discourse suggests a strong promotion of CRISPR, but an element of caution is also evident. Technical as well as ethical, legal, and social risks/concerns play a prominent role. This media portrayal of CRISPR might help facilitate more sophisticated and balanced policy responses, where the scientific potential of the technology is highlighted alongside broader social considerations.",
keywords = "biotechnology, CRISPR, ELSI, gene editing, media",
author = "Alessandro Marcon and Zubin Master and Vardit Ravitsky and Timothy Caulfield",
year = "2019",
month = "1",
day = "1",
doi = "10.1038/s41436-019-0482-5",
language = "English (US)",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - CRISPR in the North American popular press

AU - Marcon, Alessandro

AU - Master, Zubin

AU - Ravitsky, Vardit

AU - Caulfield, Timothy

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: CRISPR is often called one of the century’s most important discoveries and is commonly discussed in terms of its momentous potential impacts. This study analyzed how CRISPR is discussed in the North American popular press, including how it is defined, and which benefits and risks/concerns are attributed to the technology. Methods: Using the Factiva database, we identified 228 relevant, nonduplicated articles containing either “CRISPR” or “C.R.I.S.P.R.,” published in popular US and Canadian news sources between 1 January 2012 and 12 July 2017. Content analysis was performed on the articles. Results: CRISPR is most often discussed in the context of human health (83.8%), compared with animals (26.3%) and plants (20.6%). Nearly all articles (96.1%) presented CRISPR’s potential benefits; 61.4% of articles presented CRISPR-related risks/concerns, the vast majority of which focused on the uncertainty surrounding CRISPR, specifically with respect to germline modifications. Conclusions: Overall, the discourse suggests a strong promotion of CRISPR, but an element of caution is also evident. Technical as well as ethical, legal, and social risks/concerns play a prominent role. This media portrayal of CRISPR might help facilitate more sophisticated and balanced policy responses, where the scientific potential of the technology is highlighted alongside broader social considerations.

AB - Purpose: CRISPR is often called one of the century’s most important discoveries and is commonly discussed in terms of its momentous potential impacts. This study analyzed how CRISPR is discussed in the North American popular press, including how it is defined, and which benefits and risks/concerns are attributed to the technology. Methods: Using the Factiva database, we identified 228 relevant, nonduplicated articles containing either “CRISPR” or “C.R.I.S.P.R.,” published in popular US and Canadian news sources between 1 January 2012 and 12 July 2017. Content analysis was performed on the articles. Results: CRISPR is most often discussed in the context of human health (83.8%), compared with animals (26.3%) and plants (20.6%). Nearly all articles (96.1%) presented CRISPR’s potential benefits; 61.4% of articles presented CRISPR-related risks/concerns, the vast majority of which focused on the uncertainty surrounding CRISPR, specifically with respect to germline modifications. Conclusions: Overall, the discourse suggests a strong promotion of CRISPR, but an element of caution is also evident. Technical as well as ethical, legal, and social risks/concerns play a prominent role. This media portrayal of CRISPR might help facilitate more sophisticated and balanced policy responses, where the scientific potential of the technology is highlighted alongside broader social considerations.

KW - biotechnology

KW - CRISPR

KW - ELSI

KW - gene editing

KW - media

UR - http://www.scopus.com/inward/record.url?scp=85064258395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064258395&partnerID=8YFLogxK

U2 - 10.1038/s41436-019-0482-5

DO - 10.1038/s41436-019-0482-5

M3 - Article

C2 - 30976097

AN - SCOPUS:85064258395

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

ER -